Curious to see your top suppliers emissions?
Book a demo for a pilot project
Cambrex Corporation
Medicinal and Botanical ManufacturingUnited StatesNYSE: CBM
Last verified 17 days agocambrex.com
Cambrex Corporation, a leading global contract development and manufacturing organisation (CDMO), is headquartered in the United States. Founded in 1981, Cambrex has established itself as a key player in the pharmaceutical industry, specialising in the development and production of small molecule active pharmaceutical ingredients (APIs) and finished dosage forms.
With operational facilities across North America and Europe, Cambrex offers a comprehensive range of services, including custom synthesis, process development, and analytical testing. The company is renowned for its commitment to quality and innovation, which has positioned it as a trusted partner for pharmaceutical companies worldwide. Notable achievements include significant investments in state-of-the-art manufacturing capabilities, enhancing its market position as a preferred supplier in the competitive landscape of drug development and production.
18
DitchCarbon score
-6 vs industry average
Cambrex Corporation’s score of 18 is lower than 40% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Cambrex Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Medicinal and Botanical Manufacturing is among the most carbon-intensive industries
Industry performance
0.420
20182025
The Medicinal and Botanical Manufacturing industry has reduced its overall emissions by 28% since 2018
Reported emissions
No reported emissions data is available for Cambrex Corporation yet.
Cambrex Corporation's reported carbon emissions
Cambrex Corporation, headquartered in the United States, has not reported any carbon emissions data for the most recent year. However, the company has set ambitious climate commitments through the Science Based Targets initiative (SBTi). Cambrex aims to reduce its absolute Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 51.6% by 2030, using 2018 as the base year. Additionally, the company is committed to a 42% reduction in absolute Scope 3 GHG emissions, which include emissions from purchased goods and services, fuel- and energy-related activities, and upstream transportation and distribution, with a base year of 2020.
These targets align with the global effort to limit warming to 1.5°C, demonstrating Cambrex's commitment to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. The company is currently on track to meet these near-term targets, reflecting a proactive approach to addressing climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Cambrex Corporation’s Climate Goals (2030 & 2050)
3 goals2030
51.6% reduction in Scope 2
Cambrex Corporation commits to reduce absolute scope 2 GHG emissions 51.6% by 2030 from a 2018 base year.
Insufficient data51.6%
2030
51.6% reduction in Scope 1
Cambrex Corporation commits to reduce absolute scope 1 GHG emissions 51.6% by 2030 from a 2018 base year.
Insufficient data51.6%
2030
42% reduction in scope 3 upstream
Cambrex Corporation also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel- and energy-related activi…
Insufficient data42%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Cambrex Corporation17 days ago
18
Frequently asked questions
Common questions about Cambrex Corporation’s sustainability data and climate commitments
In 2022, Cambrex Corporation reported total greenhouse gas emissions of approximately 26 million kg CO₂e. This includes around 17.5 million kg CO₂e from Scope 1 emissions and about 6.6 million kg CO₂e from Scope 2 emissions. These figures highlight the company's carbon footprint and its commitment to tracking emissions as part of its sustainability strategy.
Data year: 2022
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more